Amyloidosis: Clinical Trials

1 trial for Amyloidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Amyloidosis: new trials by email Literature Review of Amyloidosis trials Research Report on Amyloidosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis
Thalidomide, Cyclophosphamide - Immunoglobulin Light-Chain Amyloidosis
Phase 4UnknownGuangdong Provincial People's Hospital702020-01-012020-11-03

Narrower conditions

Immunoglobulin Light-chain Amyloidosis (1)

Broader conditions

Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoproliferative Disorders (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Plasma Cell (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Paraproteinemias (1)  ·  Proteostasis Deficiencies (1)

Interventions

Bortezomib (1)  ·  Cyclophosphamide (1)  ·  Thalidomide (1)

Sponsors

Guangdong Provincial People's Hospital (1)

Countries

China (1)

Top investigators

Wenjian Wang, PhD (1)